Evidence map›Paper›PMID 41278922›Full record

ArticlebioRxiv : the preprint server for biology2025

The 9-1-1 complex protects ssDNA gaps in BRCA2-deficient cancer.

Helen E Grimsley, Katherine Courtemanche, Shane Cox, Niamh McDermott, Aman Sharma, Jackson Bright, Jeremy Setton, Mehmet Orman, Simon N Powell

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Helen E GrimsleyMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0003-3485-0305
Katherine CourtemancheMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Shane CoxMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Niamh McDermottMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Aman SharmaMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0003-1017-8307
Jackson BrightMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Jeremy SettonMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0002-0263-2306
Mehmet OrmanMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0001-8499-9154
Simon N PowellMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Funding

Targeting Polθ to Overcome PARP Inhibitor Resistance in Homologous Recombination Deficient Breast CancerP50CA247749 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Sarat Chandarlapaty, Simon N. Powell · 2020 to 2026
$16.3M
Backup DNA repair in homologous recombination deficient cancersR01CA286111 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Simon N. Powell · 2025 to 2026
$975k
NCI NIH HHS P50 CA247749NCI NIH HHS R01 CA286111
6 · The paper itself

Abstract

Single-stranded DNA (ssDNA) gaps are a hallmark of BRCA-deficient cells, yet the mechanisms that safeguard these lesions remain unclear. Through a genome-wide CRISPR screen, we identified the RAD9A-HUS1-RAD1 (9-1-1) complex as essential for the survival of BRCA2-deficient cells through an ATR-independent mechanism. Loss of 9-1-1 in this context leads to the accumulation of PRIMPOL-dependent gaps that fail to undergo post-replicative repair, resulting in pathological expansion and increased DNA damage. This instability is driven by excessive EXO1-mediated degradation, as EXO1 depletion rescues the phenotype. We further demonstrate that the 9-1-1 complex is required for POLζ-dependent gap filling. We propose a model in which ssDNA gaps, when extended beyond a critical length, become inaccessible to TLS-mediated repair and are fully reliant on homologous recombination. These findings establish the 9-1-1 complex as key regulator of ssDNA gap stability and a promising therapeutic target in BRCA2-deficient cancers.

Indexed as

9-1-1 complexATRBRCA1/BRCA2EXO1 synthetic lethalgap protectionhomologous recombinationPOLζPRIMPOLreplication gapsssDNAtranslesion synthesis

Identifiers

PMID41278922
PMCPMC12632636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.